Highest development stage: Phase 2

Development status: Inactive

Gram-positive activity

Gram-negative activity

Mechanism of Action/Target pathogen: Currently in phase II for diabetic patients, however, this has Gram positive and negative activity, explored by Transcell Technologies in 1996.

Additional information: Mintz CS, Kogan N, Kakarla R, et al. Antibacterial activity and cell permeabilising properties of a novel class of steroid poylamine conjugates. 36th-Intersci-Conf-Antimicrobial-Agents-Chemother 1996; 142.